METASTATIC UROTHELIAL CARCINOMA
Clinical trials for METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail trial targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase trial tested combinations of drugs (bevacizumab, temsirolimus, valproic acid, or cetuximab) in 154 adults with advanced cancers or certain non-cancerous diseases that are progressive and life-limiting. The main goal was to find the safest doses and understand sid…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
Bladder cancer combo trial halted early after just 4 patients
Disease control TerminatedThis study tested a combination of two drugs, selinexor and pembrolizumab, for people with advanced bladder cancer who either could not take the standard chemotherapy cisplatin or whose cancer had worsened after cisplatin. The goal was to find the best dose and see if the combina…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mamta Parikh • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New drug combo shows promise for Tough-to-Treat bladder cancer
Disease control TerminatedThis study tested a combination of two drugs (pemigatinib and pembrolizumab) against standard treatments for people with advanced bladder cancer that has a specific genetic change (FGFR3 mutation). Participants had not received prior treatment and could not take the chemotherapy …
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 04:15 UTC